Vascular Health and Risk Management
Volume 18, 2022 - Issue
Open access
185
Views
4
CrossRef citations to date
0
Altmetric
REVIEW
PCSK9 Inhibitors in the Management of Cardiovascular Risk: A Practical Guidance
Xiaoming Jia1 Department of Medicine, Baylor College of Medicine, Houston, TX, USA
, Mahmoud Al Rifai1 Department of Medicine, Baylor College of Medicine, Houston, TX, USA
https://orcid.org/0000-0002-6933-790X
Anum Saeed2 Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
, Christie M Ballantyne1 Department of Medicine, Baylor College of Medicine, Houston, TX, USA
& Salim S Virani1 Department of Medicine, Baylor College of Medicine, Houston, TX, USA;3 Department of Medicine, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USACorrespondence[email protected]
https://orcid.org/0000-0001-9541-6954
Pages 555-566
|
Published online: 20 Jul 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.